The neurology of enteric disease

Wills, A. J.; Tengah, D. S. N. A.Pengiran; Holmes, G. K. T.
July 2006
Journal of Neurology, Neurosurgery & Psychiatry;Jul2006, Vol. 77 Issue 7, p805
Academic Journal
The article reflects on the neurological complications of patients with gastrointestinal, hepatic and pancreatic disease. The failure of liver in the development of different neuropathologies has been examined. Most published evidence suggesting that gluten-sensitive enteropathy, inflammatory bowel and pancreatic disease are associated with neurological complications are at the level of case reportage.


Related Articles

  • Increased short- and long-term risk of inflammatory bowel disease after Salmonella or Campylobacter gastroenteritis.  // Inflammatory Bowel Disease Monitor;Apr2009, Vol. 10 Issue 2, p70 

    The article discusses a study concerning the increased short and long term risk of inflammatory bowel disease (IBD) after an initial diagnosis of Salmonella or Campylobacter gastroenteritis in the U.S. It mentions that the study was generated from population and case-controlled trial with...

  • Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Bernstein, Charles N.; Shanahan, Fergus // Gut;Sep2008, Vol. 57 Issue 9, p1185 

    The article offers a perspective on some of the more consistent epidemiological observations in inflammatory bowel diseases (IBD). It attempts to reconcile them with current concepts of disease mechanisms. The article discusses the environmental or lifestyle risk factors associated with IBD. It...

  • SAGES/ISUCRS 2014 GP Update. Levin, Dion // South African Gastroenterology Review;Nov2014, Vol. 12 Issue 3, preceding p29 

    The article discusses a general practice update on chronic diarrhoea, inflammatory bowel disease and upper and lower gastrointestinal bleeding at Society of American Gastrointestinal and Endoscopic Surgeons (SAGES/ISURS) Congress that was held at the Cape Town Convention Centre on 4 September 2014.

  • Sulfasalazine and New Analogues. Friedman, Gerald // American Journal of Gastroenterology;Feb1986, Vol. 81 Issue 2, p141 

    Discusses research which focused on the use of sulfasalazine drugs for the treatment and prophylaxis of inflammatory bowel disease. Composition of the drug; Analysis of the efficacy of Pentasa in treating Crohn's disease; Contribution of Poly-ASA sulfasalazine oral formulation to the medical...

  • Carcinoid Tumor and Inflammatory Bowel Disease: A Study of Eleven Cases and Review of the Literature. Greenstein, Adrian J.; Balasubramanian, Sankar; Harpaz, Noam; Rizwan, Mohammed; Sachar, David B. // American Journal of Gastroenterology;Apr1997, Vol. 92 Issue 4, p682 

    Objectives: To determine the frequency and outcome of carcinoid tumors in a large series of patients with inflammatory bowel disease (IBD). Methods: Eleven patients with carcinoid tumors associated with IBD were admitted or readmitted to The Mount Sinai Hospital between 1960 and 1995. These...

  • Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage. D Foell // Gut;Jun2009, Vol. 58 Issue 6, p859 

    It is a common experience that gastrointestinal symptoms urge us to differentiate inflammatory bowel disease (IBD) from functional disorders. Furthermore, in patients with proven IBD the disease activity has to be accurately monitored. Faecal markers of neutrophil influx into the mucosa are...

  • MORTALITY IN CROHN'S DISEASE. Hughes, Glenys // Journal of Epidemiology & Community Health;Aug2006, Vol. 60 Issue 8, p736 

    The article reports on the findings of the survey conducted by the European Collaborative Study Group of Inflammatory Bowel Disease on 380 patients diagnosed suffering from the disease between 1991 and 1993. Deaths linked to Crohn's disease increased 10 years after being diagnosed, with age...

  • Pediatric malakoplakia of colon: a report of two cases. Divya, P.; Crasta, Julian A. // Pediatric Surgery International;Mar2010, Vol. 26 Issue 3, p323 

    Gastrointestinal system is the second most common site for the occurrence of malakoplakia. We report two cases of pediatric colonic malakoplakia with the endoscopic and characteristic histologic findings. Malakoplakia is rare in pediatric age group, no clinical and endoscopic findings are...

  • Clinical Assessment of Disease Activity for Canine Inflammatory Bowel Disease. Jergens, Albert E. // Journal of the American Animal Hospital Association;Nov2004, Vol. 40 Issue 6, pN.PAG 

    Clinical indices, consisting of gastrointestinal signs and laboratory parameters, are widely used for assessing disease activity in human inflammatory bowel disease (IBD). The development of a standardized scoring index for use in dogs with IBD would be useful in the management of clinical...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics